Cargando…

Olaparib Is a Mitochondrial Complex I Inhibitor That Kills Temozolomide-Resistant Human Glioblastoma Cells

Glioblastoma represents the highest grade of brain tumors. Despite maximal resection surgery associated with radiotherapy and concomitant followed by adjuvant chemotherapy with temozolomide (TMZ), patients have a very poor prognosis due to the rapid recurrence and the acquisition of resistance to TM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zampieri, Luca X., Sboarina, Martina, Cacace, Andrea, Grasso, Debora, Thabault, Léopold, Hamelin, Loïc, Vazeille, Thibaut, Dumon, Elodie, Rossignol, Rodrigue, Frédérick, Raphaël, Sonveaux, Etienne, Lefranc, Florence, Sonveaux, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584761/ https://www.ncbi.nlm.nih.gov/pubmed/34769368 http://dx.doi.org/10.3390/ijms222111938

Ejemplares similares

Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism
por: Cacace, Andrea, et al.
Publicado: (2016)

In Vitro and In Vivo Characterization of MCT1 Inhibitor AZD3965 Confirms Preclinical Safety Compatible with Breast Cancer Treatment
por: Benyahia, Zohra, et al.
Publicado: (2021)

Mitochondria in cancer
por: Grasso, Debora, et al.
Publicado: (2020)

Discovery of a novel lactate dehydrogenase tetramerization domain using epitope mapping and peptides
por: Thabault, Léopold, et al.
Publicado: (2021)

Statins Alleviate Tumor Hypoxia in Prostate Cancer Models by Decreasing Oxygen Consumption: An Opportunity for Radiosensitization?
por: d’Hose, Donatienne, et al.
Publicado: (2022)

Monocarboxylate transporters in the brain and in cancer()
por: Pérez-Escuredo, Jhudit, et al.
Publicado: (2016)

Lactate stimulates CA IX expression in normoxic cancer cells
por: Panisova, Elena, et al.
Publicado: (2017)

Lactate does not activate NF-κB in oxidative tumor cells
por: Van Hée, Vincent F., et al.
Publicado: (2015)

Mitochondrial Transfer in Cancer: A Comprehensive Review
por: Zampieri, Luca X., et al.
Publicado: (2021)

ROS and radiotherapy: more we care
por: Sonveaux, Pierre
Publicado: (2017)

Inhibition of Mitochondrial Redox Signaling with MitoQ Prevents Metastasis of Human Pancreatic Cancer in Mice
por: Capeloa, Tania, et al.
Publicado: (2022)

VRK1 Depletion Facilitates the Synthetic Lethality of Temozolomide and Olaparib in Glioblastoma Cells
por: Navarro-Carrasco, Elena, et al.
Publicado: (2021)

Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2‐Year Durable Response
por: Valiakhmetova, Andge, et al.
Publicado: (2019)

Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer
por: Cecchini, Michael, et al.
Publicado: (2023)

Radiosynthesis and validation of (±)-[(18)F]-3-fluoro-2-hydroxypropionate ([(18)F]-FLac) as a PET tracer of lactate to monitor MCT1-dependent lactate uptake in tumors
por: Van Hée, Vincent F., et al.
Publicado: (2017)

Targeting Tumor Perfusion and Oxygenation to Improve the Outcome of Anticancer Therapy
por: Jordan, Bénédicte F., et al.
Publicado: (2012)

Olaparib and temozolomide in desmoplastic small round cell tumors: a promising combination in vitro and in vivo
por: van Erp, Anke E. M., et al.
Publicado: (2020)

Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial
por: Hanna, Catherine, et al.
Publicado: (2020)

MitoQ Prevents Human Breast Cancer Recurrence and Lung Metastasis in Mice †
por: Capeloa, Tania, et al.
Publicado: (2022)

(+)-Catechin in a 1:2 Complex with Lysine Inhibits Cancer Cell Migration and Metastatic Take in Mice
por: Payen, Valéry L., et al.
Publicado: (2017)

PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status
por: Fulton, Ben, et al.
Publicado: (2017)

Translesion DNA synthesis mediates acquired resistance to olaparib plus temozolomide in small cell lung cancer
por: Stanzione, Marcello, et al.
Publicado: (2022)

Pathological effects of ionizing radiation: endothelial activation and dysfunction
por: Baselet, Bjorn, et al.
Publicado: (2018)

Targeting Endothelial Cell Metabolism by Inhibition of Pyruvate Dehydrogenase Kinase and Glutaminase-1
por: Schoonjans, Céline A., et al.
Publicado: (2020)

Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol
por: Lesueur, Paul, et al.
Publicado: (2019)

Ffar2 expression regulates leukaemic cell growth in vivo
por: Bindels, Laure B, et al.
Publicado: (2017)

Fitter Mitochondria Are Associated With Radioresistance in Human Head and Neck SQD9 Cancer Cells
por: Grasso, Debora, et al.
Publicado: (2020)

Poly ADP Ribose Polymerase Inhibitor Olaparib Targeting Microhomology End Joining in Retinoblastoma Protein Defective Cancer: Analysis of the Retinoblastoma Cell-Killing Effects by Olaparib after Inducing Double-Strand Breaks
por: Jiang, Yuning, et al.
Publicado: (2021)

Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome
por: File, Danielle M., et al.
Publicado: (2020)

Anticancer Targets in the Glycolytic Metabolism of Tumors: A Comprehensive Review
por: Porporato, Paolo E., et al.
Publicado: (2011)

MitoQ Inhibits Human Breast Cancer Cell Migration, Invasion and Clonogenicity
por: Capeloa, Tania, et al.
Publicado: (2022)

PARP inhibition utilized in combination therapy with Olaparib‐Temozolomide to achieve disease stabilization in a rare case of BRCA1‐mutant, metastatic myxopapillary ependymoma
por: Mahalingam, Preethika, et al.
Publicado: (2023)

B-Raf inhibitor vemurafenib in combination with temozolomide and fotemustine in the killing response of malignant melanoma cells
por: Roos, Wynand P., et al.
Publicado: (2014)

Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F
por: Esteves, Pauline, et al.
Publicado: (2019)

Olaparib in the management of ovarian cancer
por: Bixel, Kristin, et al.
Publicado: (2015)

Olaparib in Epithelial Ovarian Cancer
por: Anastasia, Paula J.
Publicado: (2016)

Olaparib: Transcending mutational barriers
por: Chandna, Abhishek
Publicado: (2019)

Olaparib and somatic BRCA mutations
por: George, Angela, et al.
Publicado: (2017)

Monocarboxylate transporters in cancer
por: Payen, Valéry L., et al.
Publicado: (2019)

Combining Carbon-Ion Irradiation and PARP Inhibitor, Olaparib Efficiently Kills BRCA1-Mutated Triple-Negative Breast Cancer Cells
por: Kawanishi, Miki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_97ihcs0f8144d6atu838iilj2p